Summary: Researchers employing computational models have made a significant leap in understanding the aggregation of alpha-synuclein protein, crucial in Parkinson’s disease development. This study marks the first to map the molecular dynamics of these proteins in detail, revealing how environmental factors like molecule crowding and ionic changes enhance aggregation.
Study a~synuclein aggregation.: Summary... - Cure Parkinson's
Study a~synuclein aggregation.
Written by
House2
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
this article seems to be pretty obsessed with crowder molecules and salt so why do they never really explain where these crowder molecules originate and why they are there and are they working on research to stifle this activity
Not what you're looking for?
You may also like...
Copper Leads to Protein Aggregation in Parkinson’s Disease
Leads to Protein Aggregation in Parkinson’s Disease July 7 2022...
Zhittya Genesis Medicine's Drug Reverses Aggregated Synuclein Accumulation in an Animal Model of Parkinson's Disease
also decrease levels of the toxic aggregated alpha-synuclein protein, which is a hallmark of PD in...
Do animal proteins cause an increase in alpha synuclein?
that indicated that animal proteins are one of the causes of alpha-synuclein, which is thought to...
LL-37, a natural antimicrobial molecule present in the brain and gut, Suppresses Alpha-synuclein Clumping in Parkinson’s
alpha-synuclein protein — a hallmark of Parkinson’s disease — and prevents their further...
Allergy drug Montelukast (aka Singulair) reduced alpha synuclein load in mice genetically engineered to over produce alpha synuclein
Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with...